THE ABNORMALITY OF N30 SOMATOSENSORY-EVOKED POTENTIAL IN IDIOPATHIC PARKINSONS-DISEASE IS UNRELATED TO DISEASE STAGE OR CLINICAL SCORES ANDINSENSITIVE TO DOPAMINE MANIPULATIONS
M. Onofrj et al., THE ABNORMALITY OF N30 SOMATOSENSORY-EVOKED POTENTIAL IN IDIOPATHIC PARKINSONS-DISEASE IS UNRELATED TO DISEASE STAGE OR CLINICAL SCORES ANDINSENSITIVE TO DOPAMINE MANIPULATIONS, Movement disorders, 10(1), 1995, pp. 71-80
We recorded short latency somatosensory evoked potentials (SEPs) to me
dian nerve stimuli in 40 patients affected by idiopathic Parkinson's d
isease (PD) classified from I to IV on the Hoehn and Yahr disability s
cale. SEPs were recorded before and after chronic administration of L-
Dopa and bromocriptine, before and after acute administration of L-Dop
a. Fourteen patients experiencing wearing off and dystonic-dyskinetic
disturbances were recorded during the occurrence of these oscillations
of their clinical status. Absent or reduced N30 components were found
in 32.5% of patients. SEPs were not modified by acute or chronic admi
nistration of L-Dopa or bromocriptine or during off and dystonic or dy
skinetic conditions. Multiple correlations of N30 with scores of the U
nified Parkinson's Disease Rating Scale showed that N30 abnormality di
d not classify patients with prominent clinical features, nor did it p
redict the outcome of treatment.